Acute Lymphoblastic Leukemia Therapeutics Industry Overview
The market for acute lymphoblastic leukemia is moderately competitive and consists of the big players as well as the mid-sized companies. Owing to the rising focus of most of the pharmaceutical companies on oncology, it is expected that few new small-sized companies will also penetrate the market in the near future.
Acute Lymphoblastic Leukemia Therapeutics Market Leaders
-
Pfizer Inc.
-
Bristol-Myers Squibb Company
-
Novartis AG
-
SymBio Pharmaceuticals Limited
-
Genmab AS
- *Disclaimer: Major Players sorted in no particular order
